Skip to content

Pharmacie CANIVET: what changed

What changed

Pharmacie CANIVET

BE 0443.306.331
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€73,901
2024 · €113,421-€39,519
Equity
€129,918
2024 · €156,017-€26,099
Cash
€81,535
2024 · €99,028-€17,493
Balance sheet total
€664,707
2024 · €757,533-€92,826

Largest movements

2024 to 2025
Assets
  • Financial fixed assets -€100,295

    down €100,295 (-43.2%), from €232,328 to €132,033

  • Receivables within one year +€60,363

    up €60,363 (+42.1%), from €143,221 to €203,584

    of which Trade receivables: +€40,561

  • Stocks and contracts -€24,905

    down €24,905 (-13.3%), from €187,287 to €162,382

  • Cash -€17,493

    down €17,493 (-17.7%), from €99,028 to €81,535

    mainly Contributions, distributions and other (-€100,000) and Receivables within one year (-€60,363)

  • Tangible fixed assets -€10,109

    down €10,109 (-11.4%), from €88,565 to €78,456

Equity and liabilities
  • Debts after one year -€48,358

    down €48,358 (-30.0%), from €160,971 to €112,612

  • Reserves -€26,099

    down €26,099 (-19.0%), from €137,417 to €111,318

  • Trade debts -€10,912

    down €10,912 (-4.8%), from €226,318 to €215,406

  • Other debts -€10,000

    down €10,000 (-9.1%), from €110,000 to €100,000

Income statement
  • Gross operating margin -€42,767

    down €42,767 (-11.5%), from €372,512 to €329,744

  • Taxes -€13,520

    down €13,520 (-35.1%), from €38,498 to €24,978

  • Staff costs +€12,141

    up €12,141 (+6.2%), from €196,403 to €208,543

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €113,421
Gross operating margin -€42,767
Staff costs -€12,141
Depreciation -€439
Other operating charges -€50
Financial income -€467
Financial charges +€2,825
Taxes +€13,520
Result 2025 €73,901
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€33,298
Investment +€95,408
Financing -€146,199
Cash 2024 €99,028
Net result for the year +€73,901
Depreciation +€14,996
Stocks and contracts +€24,905
Receivables within one year -€60,363
Deferred charges and accrued income +€388
Trade debts -€10,912
Tax, wage and social debts +€515
Other debts -€10,000
Accrued charges and deferred income -€131
Investment in fixed assets (net) +€95,408
Debts after one year -€48,358
Current portion of long-term debt +€2,269
Short-term financial debts -€109
Contributions, distributions and other -€100,000
Cash 2025 €81,535
brings cash intakes cash out
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €757,533 €664,707 -€92,826 -12.3%
Fixed assets 21/28 €320,893 €210,489 -€110,404 -34.4%
Tangible fixed assets 22/27 €88,565 €78,456 -€10,109 -11.4%
Land and buildings 22 €25,282 €22,007 -€3,275 -13.0%
Plant, machinery and equipment 23 €60,265 €55,666 -€4,599 -7.6%
Furniture and vehicles 24 €3,019 €784 -€2,235 -74.0%
Financial fixed assets 28 €232,328 €132,033 -€100,295 -43.2%
Current assets 29/58 €436,640 €454,218 +€17,578 +4.0%
Stocks and contracts in progress 3 €187,287 €162,382 -€24,905 -13.3%
Stocks 30/36 €187,287 €162,382 -€24,905 -13.3%
Amounts receivable within one year 40/41 €143,221 €203,584 +€60,363 +42.1%
Trade receivables 40 €121,125 €161,686 +€40,561 +33.5%
Other amounts receivable 41 €22,096 €41,897 +€19,802 +89.6%
Cash at bank and in hand 54/58 €99,028 €81,535 -€17,493 -17.7%
Deferred charges and accrued income 490/1 €7,104 €6,717 -€388 -5.5%
Total equity and liabilities 10/49 €757,533 €664,707 -€92,826 -12.3%
Equity 10/15 €156,017 €129,918 -€26,099 -16.7%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €137,417 €111,318 -€26,099 -19.0%
Distributable reserves 133 €137,417 €111,318 -€26,099 -19.0%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €601,516 €534,789 -€66,727 -11.1%
Amounts payable after more than one year 17 €160,971 €112,612 -€48,358 -30.0%
Financial debts 170/4 €160,971 €112,612 -€48,358 -30.0%
Amounts payable within one year 42/48 €439,900 €421,662 -€18,238 -4.1%
Current portion of amounts payable after more than one year 42 €48,976 €51,245 +€2,269 +4.6%
Financial debts 43 €15,275 €15,166 -€109 -0.7%
Credit institutions 430/8 €15,275 €15,166 -€109 -0.7%
Trade debts 44 €226,318 €215,406 -€10,912 -4.8%
Suppliers 440/4 €226,318 €215,406 -€10,912 -4.8%
Taxes, remuneration and social security 45 €39,331 €39,846 +€515 +1.3%
Taxes 450/3 €8,419 €6,174 -€2,244 -26.7%
Remuneration and social security 454/9 €30,912 €33,671 +€2,759 +8.9%
Other amounts payable 47/48 €110,000 €100,000 -€10,000 -9.1%
Accrued charges and deferred income 492/3 €646 €515 -€131 -20.3%
Remuneration, social security and pensions 62 €196,403 €208,543 +€12,141 +6.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €14,557 €14,996 +€439 +3.0%
Other operating charges 640/8 €1,718 €1,768 +€50 +2.9%
Gross operating margin 9900 €372,512 €329,744 -€42,767 -11.5%
Operating profit (loss) 9901 €159,834 €104,437 -€55,397 -34.7%
Financial income 75/76B €5,814 €5,347 -€467 -8.0%
Recurring financial income 75 €5,814 €5,347 -€467 -8.0%
Financial charges 65/66B €13,729 €10,904 -€2,825 -20.6%
Recurring financial charges 65 €13,729 €10,904 -€2,825 -20.6%
Profit (loss) for the period before taxes 9903 €151,919 €98,880 -€53,039 -34.9%
Income taxes 67/77 €38,498 €24,978 -€13,520 -35.1%
Profit (loss) for the period 9904 €113,421 €73,901 -€39,519 -34.8%
Profit (loss) for the period to be appropriated 9905 €113,421 €73,901 -€39,519 -34.8%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.